Contract research news in brief

March 11, 2013
Research and Development Accelovance, BioLamina, Clinstar LLC, Critical Path Services, PRA, PSI CRO, Radiant Development, Roche, Synta

Consolidation news in the CRO sector as Accelovance buys Radiant and PRA snaps up Clinstar, plus updates from Roche/BioLamina, PSI …

Pharma manufacturing news in brief

March 11, 2013
Business Services, Manufacturing and Production Actavis, DSM, Eisai, J&J, JJ, Marken, SAFC, Sagent Pharma

Actavis revises supply deal with Sagent, facility updates from Marken and SAFC, a supply deal for DSM plus another J&J …

merck_kgaa_serono_hq_geneva_

Growth for Merck KGaA

March 8, 2013
Research and Development

2012 saw German firm’s pharma division helping drive strong sales. Pharma revenue helped drive growth at Merck KGaA last year, with …

gsk_hq_logo_26

GSK files albiglutide in EU

March 8, 2013
Research and Development

GlaxoSmithKline has filed its investigational, long-acting diabetes drug albiglutide with the European Medicines Agency.The GLP-1 receptor agonist, which will take …

ABPI image

ABPI supply chain warning

March 7, 2013
Manufacturing and Production, Sales and Marketing ABPI, API, EFPIA

The ABPI is warning of supply chain problems which may cause a bottleneck in UK pharma manufacture this summer. The …

Roche image

Perjeta approved in EU

March 7, 2013
Sales and Marketing Perjeta, Roche

Roche’s oncology brand Perjeta has been approved in Europe to treat patients with an aggressive form of breast cancer. The …

screen_shot_2013-03-06_at_16

New developer for Life Healthcare Communications

March 6, 2013
Medical Communications, Sales and Marketing Life healthcare communications

Life Healthcare Communications has expanded its digital department with the appointment of senior software developer Adam Richardson. Richardson brings over …

screen_shot_2013-03-06_at_10

Glide Pharma appoints chief executive

March 6, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Glide Pharma

Life sciences development and device firm Glide Pharma has announced the appointment of Dr Mark Carnegie-Brown as its chief executive. …

Government changes tender regulations

March 6, 2013
Sales and Marketing GPs, NHS, coalition

The government has agreed to alter a key part of the Health and Social Care Act after GPs protested about …

UK lag in early deaths

March 5, 2013
Medical Communications, Sales and Marketing Gates, Lancet, UK

The UK is lagging behind other developed nations when it comes to preventing early deaths from a number of diseases, …

Hospira image

Hospira woes continue as GSK sues over quality failures

March 5, 2013
Manufacturing and Production GSK, Hospira

The difficulties besetting generic firm and contract manufacturer Hospira have taken a new turn with the news that one of …

Nicholson faces down critics

March 5, 2013
Medical Communications, Sales and Marketing Mid Staffs, NHS, Nicholson

Sir David Nicholson, chief executive of the NHS, has been involved in testy exchanges with MPs at the House of …

Capsugel cuts deal to buy Scotland’s Encap

March 5, 2013
Manufacturing and Production Capsugel, encap

Capsugel has bought Scotland’s Encap Drug Delivery in yet another bout of merger & acquisition (M&A) activity in the capsule …

NHS Commissioning Board appoints new director of Patient Experience

March 4, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, Churchill, NHS, UK

The NHS Commissioning Board has appointed Neil Churchill as the director of Patient Experience. In this new role Churchill will ensure that improving patient …

IPEC Americas takes aim at atypical visible particles

March 4, 2013
Manufacturing and Production AVP, IPEC Americas

The industry body representing excipient users and suppliers in the US has set up a working group to tackle the …

Risk-assessment for excipients: guideline out for comment

March 4, 2013
Manufacturing and Production GMP, risk

The European Commission has published its long-awaited risk-assessment guideline for determining the level of Good Manufacturing Practice (GMP) needed for …

EU approval for Ilaris

March 4, 2013
Sales and Marketing Ilaris, Novartis

Novartis’ Ilaris has become the first biologic approved by the European Commission to treat patients suffering acute gouty arthritis attacks …

sanofi_hq_reception_close

Zaltrap launched in UK

March 4, 2013
Sales and Marketing Sanofi, Zaltrap

Sanofi and Regeneron Pharmaceuticals’ bowel cancer drug Zaltrap has been launched in the UK today. Zaltrap (aflibercept) will be used …

Boehringer targets AML

March 1, 2013
Research and Development, Sales and Marketing AML, Boehringer

Boehringer Ingelheim is to begin a pivotal trial of its investigative treatment volasertib in patients with acute myeloid leukaemia (AML). …

Lundbeck booze pill for EU

March 1, 2013
Sales and Marketing Lundbeck, alcohol, selincro

Lundbeck’s novel pill Selincro has been given European marketing authorisation to help patients with a drink problem to cut down. …

The Gateway to Local Adoption Series

Latest content